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Recurrent Nephrotic Syndrome Induced by
Nonsteroidal Anti-inflammatory Drugs
Man-Fai Lam, Sing-Leung Lui, Wai-Kei Lo
Nonsteroidal anti-inflammatory drugs (NSAIDs) are well known potential nephrotoxic agents with a wide
range of different effects on the kidney. One less commonly seen effect is nephrotic syndrome. The following
case demonstrates the easily overlooked possibility of NSAIDs being a cause of nephrotic syndrome.
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CASE REPORT
A 78-year-old male with a history of hypertension for
7 years, on regular treatment, with paroxysmal atrial
fibrillation and hyperlipidemia was admitted into the
urologic ward in June 2000 because of acute urine
retention secondary to benign prostate hyperplasia
(BPH). His usual medication included metoprolol,
simvastatin and perindopril, which was changed to
candesartan after admission. His serum creatinine level
was about 130 +mol/L in 1998 but had risen to around
180 +mol/L on admission. Serum albumin was noted
to be 25 g/L only. Terazosin, and subsequently
doxazosin, was prescribed for the urine retention, but
without much improvement. Transurethral resection of
the prostate (TURP) was performed on 19 July 2000.
Twenty-four hour urine collection 5 days after surgery
documented proteinuria of 7.1 g/day. However, he was
discharged without further investigations.
Two months later, he was admitted again because
of urinary tract infection with significant proteinuria.
His serum creatinine was around 160 +mol/L, and
ultrasound of the kidneys showed normal-sized kidneys
(left, 11.1 cm; right, 9.8 cm). Immune markers revealed
negative results for anti-nuclear factor, anti-glomerular
basement membrane antibody, and anti-neutrophil
cytoplasmic antibodies. He had normal serum C3 and
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C4 levels,  but elevated IgG and IgA levels
(32.83 and 5.74 g/L, respectively). Serology for
hepatitis B, C and syphilis were negative. The infection
responded to cefuroxime. He was referred to our clinic
upon discharge. One month later, his creatinine level
was static at around 180 +mol/L, but the proteinuria
had spontaneously improved to 1.5 g/day. Renal biopsy
was suggested but refused by the patient. Serum
albumin subsequently rose to 35 g/L. Serum creatinine
remained around the same range on subsequent follow-
up. A provisional diagnosis of hypertensive
nephropathy with an episode of nephrotic syndrome of
unknown etiology was made.
In January 2002, he presented again with
generalized edema and frothy urine for 1 month.
Creatinine was found to be 432 +mol/L, with
proteinuria of 12.5 g/day. Serum albumin had dropped
to 17 g/L. Ultrasound of the kidneys was similar to the
previous scan. The findings of the immunologic tests
were also similar to the previous test results, except
for the normalization of immunoglobulin levels. A more
detailed drug history revealed that he had taken
analgesics prescribed by other doctors for several
months prior to and during the episode of acute urine
retention in 2000, and one month before this admission
in 2002 for his low back pain. However, he denied
taking any analgesics in between. After checking the
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computerized drug record of the Hospital Authority,
Hong Kong, the analgesic was subsequently identified
as diclofenac acid. Diclofenac acid was not prescribed
after the TURP in 2000.
Soon after the administration of diclofenac acid was
stopped, serum creatinine spontaneously fell back to
between 180 and 200 +mol/L within a month.
Retrospective analysis of the blood picture revealed
mild eosinophilia on 10 July 2000 (0.8 = 105/L) and at
admission on 1 January 2002 (0.6 = 105/L). In both
instances, it was normalized several days afterwards.
There was no increase in white cell count during this
episode and eosinophiluria was not particularly looked
for. The only urinary abnormality while not having
urinary tract infection was the presence of hyaline cast.
Ur inary  N-acety l -g lucosaminidase  and _ 1-
microglobulin was not checked due to the unavailability
of the tests in our service laboratory.
After discharge, proteinuria decreased to only
2 g/day within 2 months and serum albumin increased
to above 35 g/L within 1 month. Based on the clinical
picture, detailed drug history, and the temporal
relationship with the use and cessation of the drug,
nephrotic syndrome induced by nonsteroidal anti-
inflammatory drugs (NSAIDs) was diagnosed. The
patient was therefore advised to avoid all forms of
NSAIDs in future. On subsequent follow-ups, his renal
function and proteinuria were stable. The Figure shows
the temporal relationship between serum creatinine,
degree of proteinuria, and use of diclofenac acid.
DISCUSSION
Although there was a lack of renal biopsy proof, the
temporal relationship between the onset of nephrotic
syndrome and the administration of diclofenac acid
indicated their causal relationship. The withdrawal of
diclofenac acid after TURP in 2000 and after admission
in 2002 was followed by a reduction in the extent of
proteinuria, normalization of serum albumin and
improvement in the serum creatinine level. The mild
eosinophilia associated with the two episodes and the
subsequent normalization after cessation of diclofenac
acid added further to the supportive evidence. The likely
pathology was minimal change nephropathy induced
by NSAIDs and NSAID-induced acute interstitial
nephritis (AIN), which was more apparent in the second
episode, with acute deterioration of renal function and
eosinophilia. The polyclonal increase in IgG and IgA
in 2000 was likely to be related to the urinary tract
infection. However, as he had persistent mild
proteinuria and slightly raised baseline serum creatinine
in between the two episodes, it is highly likely that he
also has background hypertensive nephropathy, which
explains the slow but progressive rise in serum
creatinine on follow-up. This case demonstrates that
without a high index of suspicion and detailed drug
history, NSAID-induced nephrotic syndrome can be
easily overlooked.
NSAIDs may cause a variety of renal problems,
which include acute renal failure, abnormalities in
sodium, water and potassium homeostasis, AIN, chronic
renal injury and nephrotic syndrome. The two main
mechanisms for its renal toxicity are hemodynamically
and immunologically mediated. Most renal effects of
NSAIDs are hemodynamically mediated. Interstitial
nephritis and nephrotic syndrome are closely associated
and their pathogeneses are thought to be immuno-
logically mediated.
The incidence of NSAID-related AIN has been
reviewed. It was only diagnosed in 1% of 460 renal
biopsies reviewed by Abraham and Keane [1] and
0.4% of 1,500 renal biopsies and 200 autopsy specimens
Figure. Relationship between (A) serum creatinine and diclofenac acid prescription, and (B) proteinuria and diclofenac acid prescription.
The horizontal arrows indicate the period of regular diclofenac acid administration. The dotted arrows indicate the period of occasional
consumption of diclofenac acid prescribed by orthopedic surgeons. TURP = transurethral resection of the prostate.
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in a 10-year survey [2]. Nevertheless, AIN was present
in 18.6% of renal lesions associated with the use of
NSAIDs [3]. Various NSAIDs have been reported as
causing AIN [4]. Nephrotic proteinuria occurs in 80%
of NSAID-related AIN cases [4]. The clinical features
of AIN with heavy proteinuria induced by NSAIDs are
non-specific. Patients are usually elderly and may have
taken the drug for months. Symptoms and signs of
hypersensitivity are usually absent [5]. Urine
microscopy may show red blood cells and leukocytes
with a low fractional excretion of sodium. However,
the proteinuria may improve within days or weeks after
discontinuation of the responsible drug. Complete
remissions are often seen [2,6]. However, some patients
may have permanent damage resulting in chronic renal
insufficiency or even progression to end-stage renal
disease. The classical renal biopsy findings are
interstitial nephritis with only mild mesangial
proliferation. Electron microscopy typically shows
diffuse fusion of epithelial deposits similar to minimal
change nephropathy with occasional mesangial
electron-dense deposition [4]. Immunofluorescence
studies are typically normal.
NSAID-induced nephrotic syndrome may also
occur without any interstitial nephritis. About 10% to
12% of patients developing renal lesions while
receiving NSAIDs have nephrotic syndrome in which
renal biopsy shows only minimal change disease [1,3].
They usually have complete remission within a few
weeks but may have a relapse of proteinuria even if
they are not re-exposed to the drug [7]. A few cases of
membranous nephropathy have also been reported, but
the proteinuria may persist for a period of 3 months to
3 years after the responsible drug has been withdrawn
[4].
Treatment is supportive and the occult drug is
stopped. Usually, renal function will gradually improve
unless the patient has already suffered permanent
damage. Use of steroid therapy is controversial,
although there have been reports showing some
improvement in patients with drug-induced AIN with
epithelioid cell granulomas [4]. A detailed drug history
is important for making the correct diagnosis, such as
in this patient presenting with nephrotic syndrome
without significant renal impairment. The patient should
avoid any further exposure to NSAIDs, as even
cutaneous application of NSAIDs has been reported to
induce nephrotic syndrome [8].
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